[go: up one dir, main page]

MX2015008970A - Compuestos de (tieno [2,3-b] [1,5] benzoxazepin-4-il) piperazin-1-ilo de actividad doble como agonista inversos de h1/antagonistas de 5-ht2a. - Google Patents

Compuestos de (tieno [2,3-b] [1,5] benzoxazepin-4-il) piperazin-1-ilo de actividad doble como agonista inversos de h1/antagonistas de 5-ht2a.

Info

Publication number
MX2015008970A
MX2015008970A MX2015008970A MX2015008970A MX2015008970A MX 2015008970 A MX2015008970 A MX 2015008970A MX 2015008970 A MX2015008970 A MX 2015008970A MX 2015008970 A MX2015008970 A MX 2015008970A MX 2015008970 A MX2015008970 A MX 2015008970A
Authority
MX
Mexico
Prior art keywords
benzoxazepin
thieno
piperazin
compounds
inverse agonists
Prior art date
Application number
MX2015008970A
Other languages
English (en)
Other versions
MX365594B (es
Inventor
Peter Thaddeus Gallagher
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MX2015008970A publication Critical patent/MX2015008970A/es
Publication of MX365594B publication Critical patent/MX365594B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Epidemiology (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Se describe un agonista inverso de H1/antagonista del receptor 5-HT2A doble de fórmula [Fórmula I], sus usos y métodos para su preparación. (ver Fórmula).
MX2015008970A 2013-01-14 2014-01-08 Compuestos de (tieno [2,3-b] [1,5] benzoxazepin-4-il) piperazin-1-ilo de actividad doble como agonista inversos de h1/antagonistas de 5-ht2a. MX365594B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361752203P 2013-01-14 2013-01-14
PCT/US2014/010577 WO2014110065A1 (en) 2013-01-14 2014-01-08 (THIENO[2,3-b][1,5]BENZOXAZEPIN-4-YL)PIPERAZIN-1-YL COMPOUNDS AS DUAL ACTIVITY H1 INVERSE AGONISTS/5-HT2A ANTAGONISTS

Publications (2)

Publication Number Publication Date
MX2015008970A true MX2015008970A (es) 2015-09-28
MX365594B MX365594B (es) 2019-06-07

Family

ID=50023875

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015008970A MX365594B (es) 2013-01-14 2014-01-08 Compuestos de (tieno [2,3-b] [1,5] benzoxazepin-4-il) piperazin-1-ilo de actividad doble como agonista inversos de h1/antagonistas de 5-ht2a.

Country Status (25)

Country Link
US (1) US9562057B2 (es)
EP (1) EP2943498B1 (es)
JP (1) JP6100400B2 (es)
KR (1) KR101735458B1 (es)
CN (1) CN104955827B (es)
AU (1) AU2014205616B2 (es)
BR (1) BR112015015491A8 (es)
CA (1) CA2893106C (es)
CY (1) CY1119517T1 (es)
DK (1) DK2943498T3 (es)
EA (1) EA026328B1 (es)
ES (1) ES2647523T3 (es)
HR (1) HRP20171731T1 (es)
HU (1) HUE037363T2 (es)
LT (1) LT2943498T (es)
ME (1) ME02898B (es)
MX (1) MX365594B (es)
NO (1) NO2971205T3 (es)
PL (1) PL2943498T3 (es)
PT (1) PT2943498T (es)
RS (1) RS56538B1 (es)
SA (1) SA515360750B1 (es)
SI (1) SI2943498T1 (es)
WO (1) WO2014110065A1 (es)
ZA (1) ZA201504041B (es)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5602124A (en) * 1994-12-12 1997-02-11 Allelix Biopharmaceuticals, Inc. 5-HT2 receptor ligands
HU226410B1 (en) * 2003-04-22 2008-11-28 Egis Gyogyszergyar Nyilvanosan Novel polymorphous forms of olanzapine hydrochlorides, process for producing them, use thereof and pharmaceutical compositions containing them
WO2005026177A1 (en) * 2003-09-09 2005-03-24 Eli Lilly And Company Substituted piperazines of azepines, oxazepines, and thiazepines
US7807828B2 (en) * 2005-08-11 2010-10-05 Hypnion, Inc. Olanzapine analogs and methods of use thereof
AR084867A1 (es) * 2011-02-07 2013-07-10 Lilly Co Eli Compuestos de acido [(5h-pirrolo[2,1-c][1,4]benzodiazepin-11-il)piperazin-1-il]-2,2-dimetilpropanoico sustituido como antagonistas de 5-ht/agonistas inversos de actividad dual
MX341132B (es) * 2011-07-08 2016-08-09 Lilly Co Eli Compuesto (tieno [2-3-b] [1,5] benzoxazepin-4-il) piperazin-1-ilo como agonista h1 inversos/antagonistas 5-ht2a de actividad doble.
KR101596607B1 (ko) 2011-08-30 2016-02-22 일라이 릴리 앤드 캄파니 이중 활성 H1 역 효능제/5-HT2A 길항제로서의 (티에노[2,3-b][1,5]벤족사제핀-4-일)피페라진-1-일 화합물

Also Published As

Publication number Publication date
CA2893106A1 (en) 2014-07-17
PL2943498T3 (pl) 2018-01-31
HRP20171731T1 (hr) 2017-12-29
ME02898B (me) 2018-04-20
CN104955827B (zh) 2017-06-30
KR101735458B1 (ko) 2017-05-15
LT2943498T (lt) 2017-11-27
KR20150092317A (ko) 2015-08-12
US9562057B2 (en) 2017-02-07
SA515360750B1 (ar) 2017-03-05
RS56538B1 (sr) 2018-02-28
BR112015015491A8 (pt) 2018-01-23
US20150353576A1 (en) 2015-12-10
CN104955827A (zh) 2015-09-30
EP2943498B1 (en) 2017-09-06
JP2016508149A (ja) 2016-03-17
ES2647523T3 (es) 2017-12-22
WO2014110065A1 (en) 2014-07-17
EP2943498A1 (en) 2015-11-18
PT2943498T (pt) 2017-11-27
AU2014205616B2 (en) 2016-08-25
BR112015015491A2 (pt) 2017-07-11
CA2893106C (en) 2017-07-18
MX365594B (es) 2019-06-07
AU2014205616A1 (en) 2015-07-02
ZA201504041B (en) 2017-11-29
SI2943498T1 (sl) 2017-10-30
DK2943498T3 (en) 2017-10-23
NO2971205T3 (es) 2018-02-24
JP6100400B2 (ja) 2017-03-22
CY1119517T1 (el) 2018-03-07
HUE037363T2 (hu) 2018-08-28
EA026328B1 (ru) 2017-03-31
EA201591099A1 (ru) 2015-11-30

Similar Documents

Publication Publication Date Title
MX2014002473A (es) Compuestos (tieno [2,3-b] [1,5] benzoxazepin -4 -il) piperazin- 1 - ilo como angonistas inversos h1 / antagonistas 5 -ht2a de actividad doble.
UA111640C2 (uk) ПОХІДНІ [1,2,3]ТРИАЗОЛО[4,5-d]ПІРИМІДИНУ ЯК АГОНІСТИ КАНАБІНОЇДНОГО РЕЦЕПТОРА 2
MY174888A (en) Benzothiophene derivatives and compositions thereof as selective estrogen receptor degraders
MX2015010679A (es) SALES DE DERIVADOS DE 2-AMINO-1-HIDROXIETIL-8-HIDROXIQUINOLIN-2(1H )-ONA QUE TIENEN ACTIVIDAD AGONISTA DEL RECEPTOR ß2 ADRENERGICO ASI COMO ACTIVIDAD ANTAGONISTA DEL RECEPTOR MUSCARINICO M3.
MY160665A (en) Spiropiperidine compounds as orl-1 receptor antagonists
IL244706A0 (en) Novel histories of 1-(4-pyrimidinyl)-1h-pyrrolo[2,3-c]pyridine as nik inhibitors
PH12015502409A1 (en) Pyrrolo[2,3-d]pyrimidine derivatives as cb2 receptor agonists
MX341132B (es) Compuesto (tieno [2-3-b] [1,5] benzoxazepin-4-il) piperazin-1-ilo como agonista h1 inversos/antagonistas 5-ht2a de actividad doble.
MX360699B (es) Derivados de espiro [2.4] heptano puenteado substituidos por piperazina, utilizados como agonistas del receptor alx.
EP3065736A4 (en) Glucagon receptor antagonist compounds, compositions thereof, and methods of use
PL3004058T3 (pl) Związki-inhibitory acetylcholinesterazy i agoniści receptorów serotoninergicznych 5ht4, o działaniu propamięciowym, ich sposoby wytwarzania i zawierające je kompozycje farmaceutyczne
MX365594B (es) Compuestos de (tieno [2,3-b] [1,5] benzoxazepin-4-il) piperazin-1-ilo de actividad doble como agonista inversos de h1/antagonistas de 5-ht2a.
NZ710361A (en) Salts of 2-amino-1-hydroxyethyl-8-hydroxyquinolin-2(1h)-one derivatives having both β2 adrenergic receptor agonist and m3 muscarinic receptor antagonist activities
UA88242U (ru) Применение ралейкина (антагониста рецепторов интерлейкина-1) как средства гипогликемического действия
UA86581U (en) 2-AMINO-4-METHYL-9-(3,4-DIMETHOXYPHENYL)-7- OXO-3-CYANO-6,7,8,9-TETRAHYDROPYRIDO[3',2':4,5]THIENO[3,2-b]PYRIDINE
UA86580U (en) 2-AMINO-9-(4-ETHOXYPHENYL)-4-METHYL-7- OXO-3-CYANO-6,7,8,9-TETRAHYDROPYRIDO[3',2':4,5]THIENO[3,2-b]PYRIDINE
UA54879U (ru) Применение антагониста рецепторов интерлейкина-1 как средства антиоксидантного действия
IN2013MU02610A (es)
UA85092U (en) 2-AMINO-4-METHYL-7-OXO-9-(n-TOLYL)-3-CYANO-6,7,8,9-TETRAHYDROPYRIDO[3',2':4,5]THIENO[3,2-b]PYRIDINE
UA86579U (en) 2-AMINO-4-METHYL-9-(1-NAPHTHYL)-7-OXO-3-CYANO-6,7,8,9-TETRAHYDROPYRIDO[3',2':4,5]THIENO[3,2-b]PYRIDINE

Legal Events

Date Code Title Description
FG Grant or registration